We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

22 hedge funds and large institutions have $1.63M invested in Edesa Biotech in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.45% less ownership

Funds ownership: 11.22% → 9.77% (-1.5%)

15% less funds holding

Funds holding: 26 → 22 (-4)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

68% less capital inflows, than outflows

Capital inflows: $99.3K | Capital outflows: $315K

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
22
Holders Change
-4
Holders Change %
-15.38%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CIBC World Market
CIBC World Market
Ontario, Canada
+$51.9K
2
CM
CM Management
Florida
+$47.5K
3
Wells Fargo
Wells Fargo
California
+$7

Top Sellers

Rank Fund Capital Flow
1
Lynwood Capital Management
Lynwood Capital Management
Ontario, Canada
-$262K
2
Renaissance Technologies
Renaissance Technologies
New York
-$16K
3
Two Sigma Investments
Two Sigma Investments
New York
-$14.4K
4
Simplicity Solutions
Simplicity Solutions
Minnesota
-$9.12K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$6.39K

EDSA Hedge Fund Activity: Q2 2023 in Review

22 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q2 2023, worth a combined $1.63M — down 21% from $2.05M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of EDSA and 1 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 2 added.

The largest buyer was CIBC World Market, opening a new position worth an estimated $51.9K. The largest seller was Lynwood Capital Management, exiting entirely with an estimated $262K sold.

  • 22 institutional investors held Edesa Biotech (EDSA) as of Q2 2023, down from 26 in Q1 2023.
  • Funds reported $1.63M of Edesa Biotech stock for Q2 2023, down 21% quarter-over-quarter.
  • 1 fund opened new Edesa Biotech positions in Q2 2023 and 5 closed out, a net change of -4 holders.
  • The largest Edesa Biotech buyer in Q2 2023 was CIBC World Market, an estimated $51.9K added.
  • The largest Edesa Biotech seller in Q2 2023 was Lynwood Capital Management, an estimated $262K sold.

Based on aggregated 13F filings for Q2 2023.